Clinical Trial

Research on Speech Development Trajectories and Predictive Models in Children With Autism Spectrum Disorder

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Recent studies indicate that children with ASD have a significantly higher risk of co-occurring speech sound disorders than typically developing children. Early atypical speech development may be a critical yet overlooked bottleneck hindering their language improvement. Given the unique phonetic features of Mandarin, it is essential to investigate speech development in Mandarin-speaking children with ASD. This study aims to construct developmental trajectories and establish early identification and prognosis prediction models for this population.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-12.
Trial Details
NCT Number NCT07472829
Lead Sponsor Children's Hospital of Chongqing Medical University
Conditions Speech, Autism Spectrum Disorder (ASD)
Enrollment 120 participants
Start Date 2026-03-10
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-17